bioRxivMicrobiology
A Type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
Abstract
CRISPR-Cas systems provide sequence-specific immunity against phages and mobile genetic elements using CRISPR-associated nucleases guided by short CRISPR RNAs (crRNAs). Type III systems exhibit a robust immune response that can lead to the extinction of a phage population, a feat coordinated by a multi-subunit effector complex that destroys invading DNA and RNA. Here, we demonstrate that a model Type III system in Staphylococcus epidermidis relies upon the activities of two degradosome-associated nucleases, PNPase and RNase J2, to mount a successful defense. Genetic, molecular, and biochemical analyses reveal that PNPase promotes crRNA maturation, and both nucleases are required for efficient clearance of phage-derived nucleic acids. Furthermore, functional assays show that RNase J2 is essential for immunity against diverse mobile genetic elements originating from plasmid and phage. Altogether, our observations reveal the evolution of a critical collaboration between two nucleic acid degrading machines which ensures cell survival when faced with phage attack.
- organism: bacteria (other)
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: gene regulatory network inference
- approach: experimental assay
- approach: biophysical modeling
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Critical roles for 'housekeeping' nucleases in Type III CRISPR-Cas immunity
L. Chou-Zheng, A. Hatoum-Aslan·bioRxiv·Jul 18, 2022
- Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection
D. Mayo-Munoz, L. M. Smith, … P. C. Fineran·bioRxiv·Jun 20, 2022
- A nucleus-forming jumbophage evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity
L. M. Malone, S. L. Warring, … P. C. Fineran·bioRxiv·Sep 25, 2019
- The Cas10 nuclease activity relieves host dormancy to facilitate spacer acquisition and retention during type III-A CRISPR immunity
Naama Aviram, Amanda K. Shilton, … Luciano A. Marraffini·Cell Host & MicrobePeer-reviewed·Dec 1, 2024
- A CARF-HAD phosphatase effector provides immunity during the type III-A CRISPR-Cas response
Gianna Stella, Linzhi Ye, … Luciano A. Marraffini·Nucleic Acids ResearchPeer-reviewed·Nov 26, 2025
- Phage genome cleavage enables resuscitation from Cas13-induced bacterial dormancy
M. C. Williams, A. E. Reker, … A. J. Meeske·bioRxiv·Jul 5, 2022